These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19890967)

  • 41. Recent insights into the pathogenesis of hepatic encephalopathy and treatments.
    Sturgeon JP; Shawcross DL
    Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):83-100. PubMed ID: 24236755
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Ammonia as a cause for hepatic encephalopathy].
    Naimushin A; Livneh A
    Harefuah; 2010 Feb; 149(2):113-4, 123. PubMed ID: 20549931
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis.
    Shawcross DL; Sharifi Y; Canavan JB; Yeoman AD; Abeles RD; Taylor NJ; Auzinger G; Bernal W; Wendon JA
    J Hepatol; 2011 Apr; 54(4):640-9. PubMed ID: 21163546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potential targeted therapies for the inflammatory pathogenesis of hepatic encephalopathy.
    Luo M; Liu H; Hu SJ; Bai FH
    Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):665-73. PubMed ID: 26216028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatic Encephalopathy Aggravated by Systemic Inflammation.
    Manzhalii E; Virchenko O; Falalyeyeva T; Moiseienko V; Nykula T; Kondratiuk V; Savchuk O; Beregova T; Stremmel W
    Dig Dis; 2019; 37(6):509-517. PubMed ID: 31170723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatic encephalopathy in alcoholic cirrhosis.
    Butterworth RF
    Handb Clin Neurol; 2014; 125():589-602. PubMed ID: 25307598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation.
    Shawcross D; Jalan R
    Cell Mol Life Sci; 2005 Oct; 62(19-20):2295-304. PubMed ID: 16158192
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pathophysiology of Hepatic Encephalopathy.
    Jaffe A; Lim JK; Jakab SS
    Clin Liver Dis; 2020 May; 24(2):175-188. PubMed ID: 32245525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changing face of hepatic encephalopathy: role of inflammation and oxidative stress.
    Seyan AS; Hughes RD; Shawcross DL
    World J Gastroenterol; 2010 Jul; 16(27):3347-57. PubMed ID: 20632436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene expression profiling in the cerebral cortex of patients with cirrhosis with and without hepatic encephalopathy.
    Görg B; Bidmon HJ; Häussinger D
    Hepatology; 2013 Jun; 57(6):2436-47. PubMed ID: 23325665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical science workshop: targeting the gut-liver-brain axis.
    Patel VC; White H; Støy S; Bajaj JS; Shawcross DL
    Metab Brain Dis; 2016 Dec; 31(6):1327-1337. PubMed ID: 26446022
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis.
    Shawcross DL; Davies NA; Williams R; Jalan R
    J Hepatol; 2004 Feb; 40(2):247-54. PubMed ID: 14739095
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ammonia and endogenous benzodiazepine-like compounds in the pathogenesis of hepatic encephalopathy.
    Venturini I; Corsi L; Avallone R; Farina F; Bedogni G; Baraldi C; Baraldi M; Zeneroli ML
    Scand J Gastroenterol; 2001 Apr; 36(4):423-5. PubMed ID: 11336169
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alkalemia and Hepatic Encephalopathy in a Chronic Dialysis Patient.
    Duriseti P; Mamtani R; Madias NE; Strom JA
    Am J Med Sci; 2021 Aug; 362(2):207-210. PubMed ID: 34092398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multidrug resistance-associated protein 4 expression in ammonia-treated cultured rat astrocytes and cerebral cortex of cirrhotic patients with hepatic encephalopathy.
    Jördens MS; Keitel V; Karababa A; Zemtsova I; Bronger H; Häussinger D; Görg B
    Glia; 2015 Nov; 63(11):2092-2105. PubMed ID: 26102310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevation of Autoantibodies to Cerebral Proteins in Hepatic Encephalopathy: Another Pathogenic Factor?
    Manzhalii EG; Falalyeyeva TM; Moyseyenko VO; Weiskirchen R; Stremmel W
    Dig Dis; 2022; 40(2):232-238. PubMed ID: 33839722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatic encephalopathy: a dynamic or static condition.
    Stewart CA; Cerhan J
    Metab Brain Dis; 2005 Sep; 20(3):193-204. PubMed ID: 16167197
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood ammonia in patients with chronic liver diseases: A better defined role in clinical practice.
    Mallet M; Desplats V; Bouzbib C; Sultanik P; Alioua I; Rudler M; Weiss N; Thabut D
    Anal Biochem; 2022 Nov; 657():114873. PubMed ID: 36108794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatic Encephalopathy: Current and Emerging Treatment Modalities.
    Fallahzadeh MA; Rahimi RS
    Clin Gastroenterol Hepatol; 2022 Aug; 20(8S):S9-S19. PubMed ID: 35940731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimental hepatic encephalopathy causes early but sustained glial transcriptional changes.
    Claeys W; Van Hoecke L; Lernout H; De Nolf C; Van Imschoot G; Van Wonterghem E; Verhaege D; Castelein J; Geerts A; Van Steenkiste C; Vandenbroucke RE
    J Neuroinflammation; 2023 May; 20(1):130. PubMed ID: 37248507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.